-
AVTE Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Aerovate Therapeutics (AVTE)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 31.12 mm | 31.12 mm | 31.12 mm | 31.12 mm | 31.12 mm | 31.12 mm |
Cash burn (monthly) | (no burn) | 88.75 k | 5.80 mm | 7.52 mm | 5.35 mm | 6.25 mm |
Cash used (since last report) | n/a | 471.69 k | 30.84 mm | 39.98 mm | 28.42 mm | 33.20 mm |
Cash remaining | n/a | 30.64 mm | 271.22 k | -8.86 mm | 2.69 mm | -2.08 mm |
Runway (months of cash) | n/a | 345.3 | 0.0 | -1.2 | 0.5 | -0.3 |
13F holders | Current |
---|---|
Total holders | 83 |
Opened positions | 24 |
Closed positions | 21 |
Increased positions | 25 |
Reduced positions | 13 |
13F shares | Current |
---|---|
Total value | 79.59 bn |
Total shares | 39.07 mm |
Total puts | 268.60 k |
Total calls | 185.70 k |
Total put/call ratio | 1.4 |
Largest owners | Shares | Value |
---|---|---|
Ra Capital Management | 9.19 mm | $24.36 bn |
Sofinnova Investments | 3.76 mm | $9.96 bn |
Sofinnova Venture Partners X | 3.76 mm | $72.81 mm |
Atlas Venture Associates XII | 3.10 mm | $61.89 mm |
TCG Crossover Management | 2.24 mm | $5.94 bn |
Atlas Venture Fund XII | 2.04 mm | $62.24 mm |
Atlas Venture Life Science Advisors | 1.80 mm | $4.77 bn |
Braidwell | 1.44 mm | $3.82 bn |
Logos Global Management | 1.40 mm | $3.71 bn |
Vanguard | 1.00 mm | $2.66 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Aug 24 | Benjamin T Dake | Common Stock | Option exercise | Acquire M | No | No | 1.74 | 1,507 | 2.62 k | 14,252 |
1 Aug 24 | Benjamin T Dake | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.74 | 1,507 | 2.62 k | 0 |
31 Jul 24 | Benjamin T Dake | Common Stock | Option exercise | Acquire M | No | No | 1.74 | 11,454 | 19.93 k | 12,745 |
31 Jul 24 | Benjamin T Dake | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.74 | 10,548 | 18.35 k | 1,507 |
31 Jul 24 | Benjamin T Dake | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.74 | 906 | 1.58 k | 0 |
17 Jun 24 | Ra Capital Management | Common Stock | Buy | Acquire P | Yes | No | 1.67 | 928,110 | 1.55 mm | 7,893,678 |
14 Jun 24 | George A Eldridge | Common Stock | Sell | Dispose S | No | Yes | 25.03 | 15,000 | 375.45 k | 5,022 |
14 Jun 24 | George A Eldridge | Common Stock | Option exercise | Acquire M | No | Yes | 2.14 | 15,000 | 32.10 k | 20,022 |
14 Jun 24 | George A Eldridge | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 2.14 | 15,000 | 32.10 k | 28,763 |
14 Jun 24 | Marinus Verwijs | Common Stock | Sell | Dispose S | No | Yes | 25 | 10,600 | 265.00 k | 0 |